Ke Wang, Ke Wang, Pei-Yin Liao, Wei-Chun Chang, Cian-Ru Yang, Yu-Ting Su, . . . Wen-Lung Ma. (2024). Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKe Wang, et al. Linoleate-pazopanib Conjugation as Active Pharmacological Ingredient to Abolish Hepatocellular Carcinoma Growth. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationKe Wang, et al. Linoleate-pazopanib Conjugation as Active Pharmacological Ingredient to Abolish Hepatocellular Carcinoma Growth. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.